CarolOvertonTacketMD
Infectious Disease • Pasadena, MDAdjunct Professor, Internal Medicine, University of Maryland School of Medicine
Dr. Tacket is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
271 Peat Bog Lane
Pasadena, MD 21122Phone+1 410-360-6936
Education & Training
University of MarylandFellowship, Infectious Disease, 1983 - 1986
Yale-New Haven Medical CenterResidency, Internal Medicine, 1978 - 1981
Yale School of MedicineClass of 1978
Certifications & Licensure
MD State Medical License 1986 - 2021
Clinical Trials
- A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons
- Phase 1 Norwalk Vaccine Study Start of enrollment: 2008 Nov 01
Publications & Presentations
PubMed
- 188 citationsEquine antitoxin use and other factors that predict outcome in type A foodborne botulismCarol O. Tacket, Wayne X. Shandera, Jonathan M. Mann, Nancy T. Hargrett, Paul A. Blake
The American Journal of Medicine. 1984-05-01 - 2426 citationsVaginal microbiome of reproductive-age womenJacques Ravel, Pawel Gajer, Zaid Abdo, G. Maria Schneider, Sara S. K. Koenig
Proceedings of the National Academy of Sciences of the United States of America. 2011-03-15 - 114 citationsEfficacy of Bovine Milk Immunoglobulin Concentrate in Preventing Illness after Shigella Flexneri ChallengeCarol O. Tacket, Steven B. Binion, Eileen F. Bostwick, Genevieve Losonsky, Michael J. Roy
The American Journal of Tropical Medicine and Hygiene. 1992-09-01
Grant Support
- Clinical Trial: Phase I Study Of Intranasal Norwalk VLP Vaccine With Adjuvant &National Center For Research Resources2008–2009
- Clinical Trial: Phase I Prime-Boost Study Of VI Polysaccharide Typhoid Vaccine ANational Center For Research Resources2008–2009
- Plant Based Microbicides And Vaccines To Prevent StisNational Institute Of Allergy And Infectious Diseases2004–2008
- Phase I Randomized, Double-Blind Heterologous Prime Boost Study Of The Safety &9National Center For Research Resources2007
- Prime-Boost Study Of VI Typhoid Vaccine And Oral Typhoid Vaccine Strain CVD 909National Center For Research Resources2006
- Planning Grants For Institutional Clinical And Translational Science AwardsNational Center For Research Resources2006
- Cholera 47000: Use Of In Vivo Expression Technology To Identify Virulence FactoNational Center For Research Resources2005
- Safety/Pharmacokinetics Of Castx2 In HealthNational Center For Research Resources2004
- Mucosal Immunity And Oral Tolerance--Innate ImmunityNational Institute Of Allergy And Infectious Diseases2000–2001
- Enteric Pathogens - Mucosal Research UnitNational Institute Of Allergy And Infectious Diseases1996–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
